L-shaped association between the GA/HbA1c ratio and all-cause mortality in U.S. adults with NAFLD: a cross-sectional study from the NHANES 1999–2004

Table 4 Association of GA/HbA1c ratio with all-cause mortality after exclusion of participants with poverty income ratio deficiency

GA/HbA1c ratio	Total	Events	Model 1	Model 2	Model 3
GA/HbA1c ratio	Total	Events	HR (95%CI), P	HR (95%CI), P	HR (95%CI), P
All-cause mortality
GA/HbA1c ratio(continuous)	4,883	1,330	1.27 (1.05,1.54), 0.015	1.26 (1.06,1.49), 0.009	1.24 (1.05,1.46), 0.011
GA/HbA1c (categorical)
Tertile 1	1,549	345	1 [Reference]	1 [Reference]	1 [Reference]
Tertile 2	1,692	415	1.16 (0.96,1.39), 0.127	1.12 (0.94,1.35), 0.213	1.15 (0.96,1.38), 0.184
Tertile 3	1,642	570	1.55 (1.30,1.85), < 0.001	1.33 (1.12,1.58), 0.001	1.22 (1.02,1.47), 0.034
P for trend			< 0.001	< 0.001	0.004

Model 1: unadjusted
Model 2: adjusted for age, sex and race
Model 3: adjusted for model 2 plus education level, marital status, poverty income ratio, hypertension, diabetes, cardiovascular disease, cancer, smoker, physical activity, estimated glomerular filtration rate, body mass index and nafld fibrosis score
Abbreviation: HR Hazard ratio, CI Confidence interval

ISSN: 1472-6823